158 related articles for article (PubMed ID: 28416106)
21. Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe.
Richard PO; Jewett MA; Bhatt JR; Evans AJ; Timilsina N; Finelli A
J Urol; 2016 Mar; 195(3):581-6. PubMed ID: 26388501
[TBL] [Abstract][Full Text] [Related]
22. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
23. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
24. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
[TBL] [Abstract][Full Text] [Related]
25. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
[TBL] [Abstract][Full Text] [Related]
26. Touch preparation for rapid onsite evaluations of renal mass biopsies: concordance rate, pearls, and pitfalls.
Ponce-Zepeda J; Nowroozizadeh B; Lu D; Farzaneh T; Han M
J Am Soc Cytopathol; 2020; 9(5):422-428. PubMed ID: 32616449
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent In-situ Hybridization Study of Non-papillary Oncocytic/Eosinophilic Renal Cell Carcinoma.
Mai KT; Ahmed I; Levac J; Nguyen BN
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):82-91. PubMed ID: 20861792
[TBL] [Abstract][Full Text] [Related]
28. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
[TBL] [Abstract][Full Text] [Related]
29. Cytomorphology of clear cell papillary renal cell carcinoma.
Lin X
Cancer Cytopathol; 2017 Jan; 125(1):48-54. PubMed ID: 27636377
[TBL] [Abstract][Full Text] [Related]
30. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma.
Renshaw AA; Lee KR; Madge R; Granter SR
Acta Cytol; 1997; 41(4):987-94. PubMed ID: 9250289
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify.
Pivovarcikova K; Grossmann P; Hajkova V; Alaghehbandan R; Pitra T; Perez Montiel D; Sperga M; Rogala J; Slisarenko M; Bartos Vesela A; Svajdler P; Michalova K; Rotterova P; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2021 Jun; 52():151734. PubMed ID: 33838490
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
Alshenawy HA
Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
35. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
[TBL] [Abstract][Full Text] [Related]
36. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
37. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
38. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
[TBL] [Abstract][Full Text] [Related]
39. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
40. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]